It certainly has increased the anxiety around here, but do we have a real benchmark?The only thing that is changing is time elapsing about efficacy data with the mild to moderate trial. They were quick to get out safety but this dragging is a bit of a red flag.
If we are honest, they have trouble proving anything. They haven't even got the BLA submission for HIV right yet and everything is anecdotal. So the more time that elapses where they haven't proven anything is a red flag.It certainly has increased the anxiety around here, but do we have a real benchmark?
As compared to what?
Patterson is the cornerstone for me but if that is a false premise, this is sinking like a rock. I don't want to think about all the conflicts but they certainly are there.I think in WSJ defense Bruce Patterson is kinda like Jesus to us, to him he is one random doctor with a big conflict. If there were other credible doctors without conflicts that would have been worse to me. WSJ definitely let the story match up with what they wanted their readers to hear though (in not a good way)
What's the "normal" timeline you are comparing it to?If we are honest, they have trouble proving anything. They haven't even got the BLA submission for HIV right yet and everything is anecdotal. So the more time that elapses where they haven't proven anything is a red flag.
That being said, i added shares today at a lower price to get back to previous level. Im in it but i can see why there are doubters.
The Nader timeline when he is in a rush to post any good newsWhat's the "normal" timeline you are comparing it to?
Gotcha. That's why I view this perceived "delay" as static.The Nader timeline when he is in a rush to post any good news
I agree with all of this, which is why I am adding but also see why people are jumping ship.Took this from another board.
It is impossible for the DSMC (Data Safety Monitoring Committee) to recommend stopping CYDY's Serious/Critical COVID19 trial early for efficacy because the minimum patient count agreed to by the FDA to reach statistically relevant data is 195 patients and less than that were enrolled when the DSMC met last week. Anyone making an issue of this is lying or ignorant. The finding by the DSMC that Leronlimab has no safety concerns is huge. The fact that the DSMC did NOT REDUCE the threshold for efficacy in this instance, during this COVID19 Pandemic, is huge, because FDA is on orders from the Administration to get as many useful options approved and out there as possible and for lesser efficacious treatments the DSMCs are reducing the primary endpoints because the treatments are failing to meet them and are instead saying, to paraphrase, try to find something else that this drug is showing useful so we can approve it. Case in point in Humanagen's drug and Relief Therapeutics. Besides those, nearly all other treatments for COVID19 are failing their trials and being stopped for INEFFICACY, including two last week or so from Big Pharmas. CYDY is the only company in the lead on this. It's so obvious.
I treat the NP timelines like I do my wife’s-The Nader timeline when he is in a rush to post any good news
You mean 4.51?Sold off my 5.31 shares at 5.51. Just going to keep chipping away at my cost basis and keep cash in hand to chase this falling knife.
Eh, 20 cents is 20 cents. Just making sure I didn't miss something.Correct. Still thinking in terms of last week.
Any jokes you wanna explain today?I always find the jokes you have to explain are the funniest.
Why do you always go fishing with 2 Mormons?Any jokes you wanna explain today?
Absolutely. I know poor Whyatt feels persecuted but when I searched for that Tocilwhatever drug discussion after the post yesterday where it failed, I found his June 3rd post. He mentioned that the results would be out in early July. Well the press release was early August. Not a bash on him but I think the expectations of full efficacy results in 3 days or a couple weeks was way off. Whyatt himself said 4-6 weeks after unblinding. When did they unblind, 7/17? Well, it’ll be 3 weeks tomorrow. It’ll be a grind for a few more days. Sucks with no news but there’s nothing else to do.NP is exhausting. Any CYDY fatigue is 100% on him.
Going back to this - is it possible they miss the primary endpoint but still get EUA since there is such a need for any kind of safe covid drug?Took this from another board.
It is impossible for the DSMC (Data Safety Monitoring Committee) to recommend stopping CYDY's Serious/Critical COVID19 trial early for efficacy because the minimum patient count agreed to by the FDA to reach statistically relevant data is 195 patients and less than that were enrolled when the DSMC met last week. Anyone making an issue of this is lying or ignorant. The finding by the DSMC that Leronlimab has no safety concerns is huge. The fact that the DSMC did NOT REDUCE the threshold for efficacy in this instance, during this COVID19 Pandemic, is huge, because FDA is on orders from the Administration to get as many useful options approved and out there as possible and for lesser efficacious treatments the DSMCs are reducing the primary endpoints because the treatments are failing to meet them and are instead saying, to paraphrase, try to find something else that this drug is showing useful so we can approve it. Case in point in Humanagen's drug and Relief Therapeutics. Besides those, nearly all other treatments for COVID19 are failing their trials and being stopped for INEFFICACY, including two last week or so from Big Pharmas. CYDY is the only company in the lead on this. It's so obvious.
Definitely possible.Going back to this - is it possible they miss the primary endpoint but still get EUA since there is such a need for any kind of safe covid drug?
It's possible, but this would be a pathway few drugs have successfully navigated, so like all things leronlimab related, it's a longshot with big payoff.Going back to this - is it possible they miss the primary endpoint but still get EUA since there is such a need for any kind of safe covid drug?
Man it’s just so hard for me to reconcile how this virus is destroying the country and the fda is going to fart around with their old rules that don’t apply to the situation at hand. It’s amazing.It's possible, but this would be a pathway few drugs have successfully navigated, so like all things leronlimab related, it's a longshot with big payoff.
If I was the FDA I would have someone at Cytodyn or whatever the results currently are, looking over the shoulder of whoever is working on this data.Man it’s just so hard for me to reconcile how this virus is destroying the country and the fda is going to fart around with their old rules that don’t apply to the situation at hand. It’s amazing.
I really don’t get it. This thing is killing hundreds of thousands, taking jobs, blowing the economy...the delay is unreal. I get you need to prove it’s safe and won’t cause you to grow a third arm. After that if it has been proven to show any benefit let’s go to town.If I was the FDA I would have someone at Cytodyn or whatever the results currently are, looking over the shoulder of whoever is working on this data.
Do you really think these government workers are all that concerned that they are putting in extra work hours, etc.? It's sad especially since it's pretty obvious that none of the drugs so far have helped much at all, anymore than just hospitals having a clue how to treat it.I really don’t get it. This thing is killing hundreds of thousands, taking jobs, blowing the economy...the delay is unreal. I get you need to prove it’s safe and won’t cause you to grow a third arm. After that if it has been proven to show any benefit let’s go to town.
How are you ever gonna tell it's working if there's no controlled studies? I'm fine with what they're doing right now. If b the m/m hits ANY of the endpoints and they don't approve for EUA, then I think that's a legit gripe.I really don’t get it. This thing is killing hundreds of thousands, taking jobs, blowing the economy...the delay is unreal. I get you need to prove it’s safe and won’t cause you to grow a third arm. After that if it has been proven to show any benefit let’s go to town.
Study has been done for a couple of weeks. Put 500 people on the data if that what it takes. We would be speaking Japanese and looking at red colored moon if our gov't of days gone by was this bad.How are you ever gonna tell it's working if there's no controlled studies? I'm fine with what they're doing right now. If b the m/m hits ANY of the endpoints and they don't approve for EUA, then I think that's a legit gripe.
I believe they'll hit endpoints. My concern is how they'll package it up and draft the report. Hopefully the CEO calls in sick that day and is nowhere near the final efficacy report. No way they screw that up, right? Right!?How are you ever gonna tell it's working if there's no controlled studies? I'm fine with what they're doing right now. If b the m/m hits ANY of the endpoints and they don't approve for EUA, then I think that's a legit gripe.
Well that’s what I mean. After they get these results back.How are you ever gonna tell it's working if there's no controlled studies? I'm fine with what they're doing right now. If b the m/m hits ANY of the endpoints and they don't approve for EUA, then I think that's a legit gripe.
I’ve worked with a lot of government workers who have cared about things less important than corona. I would hope they’d have some empathy; not like they are immune from corona.Do you really think these government workers are all that concerned that they are putting in extra work hours, etc.? It's sad especially since it's pretty obvious that none of the drugs so far have helped much at all, anymore than just hospitals having a clue how to treat it.
True, but I'm considering the top down.I’ve worked with a lot of government workers who have cared about things less important than corona. I would hope they’d have some empathy; not like they are immune from corona.
Finally someone who doesn't make a living doing youtube videos mentions Cytodyn.Awaiting results for a Phase 3 study for this drug to combat cytokine storm in severe COVID-19 cases. The stock is nuts
And from my one true love (after my wife of course), no less.Sara Eisen (CNBC) tweet
Finally someone who doesn't make a living doing youtube videos mentions Cytodyn.
My notebook says the line for Sara Eisen starts with our GB @St. Louis BobAnd from my one true love (after my wife of course), no less.
She looks smartSara Eisen (CNBC) tweet
Finally someone who doesn't make a living doing youtube videos mentions Cytodyn.
Nice to see someone allegedly reputable but unless it starts getting on their shows I don’t really know what it does.Sara Eisen (CNBC) tweet
Finally someone who doesn't make a living doing youtube videos mentions Cytodyn.
Thanks for the hot take, JudasI think in WSJ defense Bruce Patterson is kinda like Jesus to us, to him he is one random doctor with a big conflict. If there were other credible doctors without conflicts left out that would have been worse to me. WSJ definitely let the story match up with what they wanted their readers to hear though (in not a good way)
Sara Eisen (CNBC) tweet
Finally someone who doesn't make a living doing youtube videos mentions Cytodyn.
 Not me but I’m stealing it! Long haulers!![]()
which one of you made the CCR5 Semi truck?
Sara Eisen is one of the few people at CNBC who has a spine these days.Sara Eisen (CNBC) tweet
Finally someone who doesn't make a living doing youtube videos mentions Cytodyn.
Its major progress. To my knowledge she is the first person at CNBC to mention this. I've been bugging themNice to see someone allegedly reputable but unless it starts getting on their shows I don’t really know what it does.
Which is ironic because her posture is terrible.Sara Eisen is one of the few people at CNBC who has a spine these days.